Rock Springs Capital Management LP Macrogenics Inc Transaction History

Rock Springs Capital Management LP

$1.67 Billion
Q1 2025

A detailed history of Rock Springs Capital Management LP transactions in Macrogenics Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,145,214 shares of MGNX stock, worth $1.86 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,145,214

Previous 1,053,647 8.69%

Holding current value

$1.86 Million

Previous $3.42 Million 57.54%

% of portfolio

0.09%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.26 - $3.49 $115,374 - $319,568	91,567 Added 8.69%	1,145,214 $1.45 Million
Q2 2024 Aug 14, 2024	SELL	$3.31 - $18.51 $832,805 - $4.66 Million	-251,603 Reduced 19.28%	1,053,647 $4.48 Million
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $1.24 Million - $2.71 Million	126,454 Added 10.73%	1,305,250 $19.2 Million
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $249,536 - $344,783	55,700 Added 4.96%	1,178,796 $5.49 Million
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $279,043 - $583,151	-83,546 Reduced 6.92%	1,123,096 $7.54 Million
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $758,261 - $1.31 Million	251,914 Added 26.39%	1,206,642 $4.18 Million
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $49,500 - $219,780	22,000 Added 2.36%	954,728 $2.82 Million
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $613,246 - $1.28 Million	75,523 Added 8.81%	932,728 $8.22 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $3.43 Million - $4.71 Million	215,389 Added 33.56%	857,205 $13.8 Million
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $3.67 Million - $5.34 Million	186,000 Added 40.81%	641,816 $13.4 Million
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $1.28 Million - $2.22 Million	62,337 Added 15.84%	455,816 $12.2 Million
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $1.59 Million - $2.79 Million	83,969 Added 27.13%	393,479 $12.5 Million
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $909,727 - $1.22 Million	46,869 Added 17.85%	309,510 $7.08 Million
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $694,406 - $888,750	28,125 Added 11.99%	262,641 $6.62 Million
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $23,483 - $131,505	4,516 Added 1.96%	234,516 $6.55 Million
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $556,500 - $858,900	-70,000 Reduced 23.33%	230,000 $2.5 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $2.43 Million - $5.61 Million	219,019 Added 270.46%	300,000 $5.39 Million
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $2.28 Million - $4.16 Million	-194,019 Reduced 70.55%	80,981 $1.03 Million
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $944,500 - $1.62 Million	50,000 Added 22.22%	275,000 $6.92 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $3.49 Million - $4.26 Million	225,000	225,000 $4.16 Million

Others Institutions Holding MGNX

# of Institutions

128

Shares Held

53.5M

Call Options Held

45.1K

Put Options Held

143K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $99.6M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Macrogenics Inc Transaction History